BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

N/A
indicator

BSE 200 Equal Weight

1D
1M
3M
6M
1Y
5Y
empty graph

BSE 200 Equal Weight Performance

Day's Range

Low

₹13,845.44

High

₹13,904.55

52 Week Range

Low

₹11,639.89

High

₹13,997.65

Previous Close ₹13,902.13
Day's Range ₹13,845.44 - ₹13,904.55
Open ₹13,893.03
52 Week Range ₹11,639.89 - ₹13,997.65
Volume 5,46,88,412

BSE 200 Equal Weight Companies

Company Name LTP (₹) Change (₹) Sector
ABB India Ltd. 7686.95 Arrow 41.95 (0.55%) Capital Goods
Bajaj Finance Ltd. 1098.20 Arrow 10.50 (0.97%) Finance
Bharat Electronics Ltd. 411.90 Arrow 1.50 (0.37%) Capital Goods
Cipla Ltd. 1426.80 Arrow -23.20 (-1.60%) Healthcare
CG Power and Industrial Solutions Ltd. 892.35 Arrow -0.65 (-0.07%) Capital Goods
Dabur India Ltd. 405.60 Arrow -2.00 (-0.49%) FMCG
Bharat Heavy Electricals Ltd. 430.50 Arrow 8.40 (1.99%) Capital Goods
Hindustan Petroleum Corporation Ltd. 372.30 Arrow -0.70 (-0.19%) Crude Oil
State Bank Of India 1065.95 Arrow -2.05 (-0.19%) Bank
Steel Authority Of India Ltd. 170.50 Arrow 1.00 (0.59%) Iron & Steel

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 24328.5 26373.20 22182.55
Nifty IT 30898.55 40301.40 25699.10
Nifty Next 50 74489.2 74878.45 59896.10
NIFTY50 USD Index 8818.05 10443.40 8132.40
Nifty Bank 57477.65 61764.85 49954.85
NIFTY Midcap 100 63798.1 64139.05 52032.85
Nifty 500 23580.15 24144.20 20385.65
Nifty Midcap 50 18272.45 18403.50 14804.55
Nifty 100 25493.1 26975.15 22720.45
Nifty FMCG 48238.8 58485.05 45334.15

Latest News

Aug
17
2026
EQUITY Posted on Aug 17th 2026

Sun Pharmaceutical Industries informs about update

Sun Pharmaceutical Industries has informed that the company and certain of its subsidiaries have been defendants in antitrust litigation in the United States relating to a 2008 patent litigation settlement agreement with Pfizer concerning generic Lipitor (Atorvastatin). Plaintiffs alleged that the settlement unlawfully delayed generic competition for Lipitor and that absent the unlawful settlement, Lipitor would have entered the market earlier than it did. The matter has been disclosed from time to time in the Company's financial statements. The United States Court of Appeals for the Third Circuit has affirmed the order of the United States District Court granting summary judgment in its entirety in favour of the Company and its subsidiaries. The Appellate Court has also affirmed the District Court's orders denying class certification as to the plaintiffs. This decision represents a significant favourable development for the Company and its subsidiaries in the matter, and brings the litigation substantially to a close, subject to any further remedies that may be available to the plaintiffs under applicable law.

The above information is a part of company’s filings submitted to BSE.  

Read More
Aug
17
2026
EQUITY Posted on Aug 17th 2026

Hero MotoCorp informs about appointment of chief strategy officer

Pursuant to Regulation 30 of the Listing Regulations, Hero MotoCorp has informed that Srihari Mulgund has been appointed as the Chief Strategy Officer of the company with effect from Monday, August 17, 2026. The requisite details as per Listing Regulations, is enclosed as Annexure A.
The above information is a part of company’s filings submitted to BSE.  
Read More
Aug
17
2026
EQUITY Posted on Aug 17th 2026

Asian Paints informs about disclosure

Asian Paints has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Smiti Holding and Trading Company.
The above information is a part of company’s filings submitted to BSE.  
Read More
Aug
17
2026
EQUITY Posted on Aug 17th 2026

Aurobindo Pharma informs about clarification

Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that: The United States Food and Drug Administration (USFDA) inspected Raleigh Plant, North Carolina, USA, owned by Aurolife Pharma LLC, a wholly owned step-down subsidiary of the Company, established for manufacturing Inhalers, Dermatology and Transdermal products, from March 24, 2025, to April 10, 2025. At the end of inspection, form 483 was issued with a total of 11 observations. The Unit has now received Establishment Inspection Report (EIR), classifying the facility as ‘Voluntary Action Indicated’ (‘VAI’). The USFDA has concluded that this inspection is now closed. As this unit is classified as VAI, pending applications for multiple inhalers and other dosage forms filed from this facility can now progress through the USFDA’s review process.
The above information is a part of company’s filings submitted to BSE.  
Read More
Aug
17
2026
EQUITY Posted on Aug 17th 2026

Kotak Mahindra Bank informs about investor presentation

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) and with reference to its intimation dated August 12, 2026 regarding the Schedule of Institutional Investors / Analyst Meetings, Kotak Mahindra Bank has informed that it enclosed the Investor Presentation for the said Meetings. No unpublished price sensitive information is contained in the aforesaid Investor Presentation. This intimation, along with the Investor Presentation, is also being made available on the Bank’s website https://www.kotak.bank.in/en/investor-relations/governance/sebi-listing-disclosures.html in terms of the Listing Regulations. 
The above information is a part of company’s filings submitted to BSE. 
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of 200EQW index?

The previous close of 200EQW index is ₹13902.13 as of 2026-08-17.

The total volume of 200EQW index is 54688412.00 as of 2026-08-17.

The percentage change in value of 200EQW index is -0.05% as of 2026-08-17.

The absolute increase in 200EQW index value since the previous trading day is ₹-6.67 as of 2026-08-17.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore